Mitochondrial ATP Preparation
Our ATP preparation is an innovative, laboratory-produced equivalent of adenosine triphosphate (ATP) – the basic energy molecule present in all living cells. Unlike naturally produced ATP, which degrades rapidly and is used inefficiently by the body (especially in conditions of aging or disease), this formulation is characterized by increased stability and durability. This allows the body to fully utilize ATP's potential as an energy carrier, neurotransmitter, and key regulator of repair and regeneration processes at the cellular level, thanks to its function in stimulating and protecting mitochondria.
Medical Research
Over 15 years of laboratory and medical research culminated in a stable molecule of a laboratory-produced equivalent of adenosine 5'-triphosphate.
Cooperation with Foreign Research Laboratories
Laboratory studies have demonstrated an increase in intracellular ATP levels by over 170% and over 100% in granulocytes.
Laboratory of the Highest Standard
Our laboratory has the highest quality equipment that guarantees the stability of the molecule synthesis, which, after hydration, creates the final preparation ready for consumption.
Years of Research Proving the Effectiveness of the Preparation
Over 15 years of research in patients with hormonal, cancer, autoimmune conditions and extreme cases of chronic wounds.
IMD Berlin Laboratory Report
The intracellular ATP level at the beginning of the study was 2.79 µM (lower reference range).
After approximately 6 weeks of using the preparation, a significant increase in intercellular ATP was observed, reaching 7.59 µM (upper reference range; additionally, no mitochondrial dysfunction was observed). This increase in ATP confirms mitochondrial stimulation and provides evidence of the effectiveness of oral administration of the preparation. On the day of the study, a daily dose of the preparation (50 ml) was also administered.
The ATP level after discontinuing the preparation for the next 6 weeks was 3.67 µM (the preparation was not taken from July 22, 2022, to October 14, 2022).
The measurement demonstrated that the effects achieved during treatment with the preparation are sustained mitochondrial stimulation, which, in the case of pathological conditions, indicates the effectiveness of limiting and eliminating changes.
ATP in Granulocytes
Granulocytes play a key role in the immune response, especially in the fight against pathogens. ATP is essential for migration, phagocytosis, and degranulation, enabling granulocytes to effectively protect the body. Granulocytes use ATP for migration and chemotaxis, enabling rapid movement to sites of infection, where they perform phagocytosis and degranulation, which also depends on their energy supply. By increasing the amount of ATP in granulocytes through natural mitochondrial stimulation, the preparation strengthens the immune response and also contributes to proper wound healing, which is another defensive function of granulocytes. Excess exogenous ATP, such as disodium adenosine, can unfortunately have a negative effect if administered excessively. However, the fundamental difference lies in the method of absorption, the preparation's formulation process, and the fact that the preparation stimulates mitochondrial ATP, thereby maintaining homeostasis.
In a study conducted on April 22, 2024, in men, the apparent ATP level in granulocytes was 0.254 nmol. After 2 months of treatment with the preparation, the ATP level increased to 0.522 nmol, i.e. by 105.5%.
In contrast, in women, an increase in ATP in granulocytes by as much as 121.3% was observed, also after 2 months of treatment.











